|
Asset Impairments, Restructuring, and Other Special Charges (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Unusual or Infrequent Item [Line Items] | |||||||||||
| Total Asset impairment, restructuring, and other special charges | $ 35.4 | $ 0 | $ 63.5 | $ 21.7 | $ 204.0 | $ 53.3 | $ 0 | $ 23.8 | $ 120.6 | $ 281.1 | $ 401.4 |
| Asset Impairment Charges | 30.0 | 206.6 | 149.6 | ||||||||
| Severance Costs | 90.6 | 74.5 | 251.8 | ||||||||
|
Xigris [Member]
|
|||||||||||
| Unusual or Infrequent Item [Line Items] | |||||||||||
| Asset Impairment Charges | 20.0 | 85.0 | |||||||||
|
Leases [Member]
|
|||||||||||
| Unusual or Infrequent Item [Line Items] | |||||||||||
| Asset Impairment Charges | 56.1 | ||||||||||
|
Device Delivery Platform [Member]
|
|||||||||||
| Unusual or Infrequent Item [Line Items] | |||||||||||
| Asset Impairment Charges | 64.0 | ||||||||||
|
Liprotamase [Member]
|
|||||||||||
| Unusual or Infrequent Item [Line Items] | |||||||||||
| Asset Impairment Charges | $ 122.6 | ||||||||||